混悬剂

  • 网络suspension
混悬剂混悬剂
  1. 助悬剂对硫酸钡混悬剂性能的影响

    Effects of suspending agents on the properties of barium sulfate suspensions

  2. 黄原胶在混悬剂和软膏中的应用

    Application of Xanthan Gum in Suspensions and Ointments

  3. 硫酸钡混悬剂用作MRI胃肠腔造影剂的研究&(Ⅰ)实验研究

    Barium Sulphate Suspension used as a Oral Contrast Agent ──ⅰ . Experimental Study

  4. 头孢泊肟酯口服干混悬剂中苯甲酸钠的HPLC测定

    Determination of Sodium Benzoate in Cefpodoxime Proxetil for Oral Suspension by HPLC

  5. 罗红霉素颗粒和干混悬剂溶出度HPLC测定法的建立

    Development of the dissolution methods for roxithromycin granules and roxithromycin for suspension by HPLC

  6. 研究维甲酸(RA)纳米颗粒混悬剂的稳定性。

    To investigate the stability of retinoic acid ( RA ) nanosuspensions .

  7. HPLC法测定复方布洛芬干混悬剂中布洛芬及苯巴比妥钠的含量

    Determination of Fenbufen Tablets by HPLC Determination of Ibuprofen and Sodium Phenobarbital in Compound Ibuprofen for Suspension by HPLC

  8. 建立了HPLC法测定雷尼酸锶干混悬剂的含量和有关物质。

    HPLC method was established for the determination of the content of strontium ranelate for suspension and its related substances .

  9. 结论:硫酸钡混悬剂有良好的阴性MRI造影效果,本研究提出的硫酸钡混悬剂可望用于临床造影。

    Conclusion : Barium Sulphate Suspension has good MRI negative contrast effect , the Suspension presented here is suitable for clinical application .

  10. 本文报道一种MRI阴性造影剂&超顺磁性氧化铁混悬剂用作胃肠腔造影剂的临床试用结果。

    The clinical application of a kind of MRI negative contrast agent-superparamagnetic iron oxide particles suspension as contrast medium for gastrointestinal tract was reported .

  11. 阿昔洛韦胃黏附型缓释混悬剂Beagle犬体内药动学

    Pharmacokinetics of stomach-bioadhesive acyclovir sustained-release suspensions in Beagle dogs

  12. FDA正在要求制订一份可提供给所有患者的有关使用纳曲酮缓释注射用混悬剂治疗的用药指南。

    The FDA is requiring that a medication guide about treatment with naltrexone extended-release injectable suspension be provided to all patients .

  13. 目的:研究受试制剂头孢克肟干混悬剂(A)、胶囊剂(B)和参比制剂(C,头孢克肟胶囊,世福素)的人体生物等效性。

    OBJECTIVE : To study the bioequivalence of suspension formulation of cefixime ( A ), capsule formulation of ce-fixime ( B ) and reference preparation ( C : Cefixime Capsules or Cefspan ) in human body .

  14. 方法:83例UM患者经超声、血管造影确诊后,超选择UM供血动脉注入白芨微粒混悬剂栓塞。

    Methods : 83 cases with uterine myoma underwent superselective embolization of the uterine myoma 's blood supply with bletilla striata particle suspension .

  15. 方法:用微生物法测定10名男性健康志愿者分别口服罗红霉素干混悬剂和片剂各150mg后的血药浓度,以观察罗红霉素干混悬剂的相对生物利用度。

    METHODS : The study was conducted in 10 male volunteers .

  16. 同皮肤细胞匀浆代谢相似,酮洛芬异丙酯被代谢成原药酮洛芬。HPLC法测定复方布洛芬干混悬剂中布洛芬及苯巴比妥钠的含量

    Ketoprofen isopropyl ester was hydrolyzed into ketoprofen when penetrated through the cultured skin , which resembled in the skin cell homogenates metabolism . Determination of Ibuprofen and Sodium Phenobarbital in Compound Ibuprofen for Suspension by HPLC

  17. 方法:狗口服NTZ干混悬剂,剂量分别为50mg/kg·bw、100mg/kg·bw和200mg/kg·bw,用HPLC法测定血药浓度,并计算药物动力学参数。

    Methods : Following administration of a single dose of 50 , 100 and 200mg / kg dry suspension of Nitazoxanide to dogs , blood drug concentrations were determined by HPLC .

  18. 本研究采用离子交换吸附技术,并用丙烯酸树脂RS100修饰GAL树脂表面,研制一种GAL缓释混悬剂。

    We designed a GAL sustained-release suspensions which prepared with the technologies both the ion-exchange adsorption and the modification of the surface of GAL-resin .

  19. 研究了健康狗口服NTZ(nitazoxanide)干混悬剂的主要活性代谢产物替唑尼特的药物动力学过程及药动学特征。

    The pharmacokinetics of the main activity metabolin of dry suspension of Nitazoxanide was studied in dogs .

  20. 目的:对炉甘石洗液处方中的常用助悬剂羧甲基纤维素钠(CMC-Na)和吐温-80(Tween-80)用量进行优选,增加混悬剂稳定性。

    Objective : To choose the best dosage of CMC-Na and Tween-80 of the calamine lotion , in order to increase the stability of the calamine lotion .

  21. 选择自然感染复孔绦虫的犬6只,按200mg/Kgbw的剂量一次口服此干混悬剂(按NTZ计100mg/Kgbw)。

    Six dogs , infected naturally with Dipylidium caninum were given 200mg / kg bw NTZ dry suspension ( equal to 100mg / kg bw NTZ ) respectively .

  22. 小鼠一次灌胃二巯基丁二酸(DMSA)混悬剂的LD(50)为6g/kg,大白鼠为4g/kg。

    After a single intragastric gavage to mice and rats , the LD_ ( 50 ) of 2,3-dimercaptosuccinic acid ( DMSA ) were found to be 6 and 4g / kg , respectively .

  23. 以沉降体积比、再分散性、pH值为考察指标,采用正交设计试验对NTZ干混悬剂处方进行筛选,并考察优选处方的流体性能、粒径分布及稳定性。

    In order to select an optimized recipe of NTZ for dry suspension , an orthogonal design experiment was carried out by determination of the ratio setting volume , redispersibility and pH value of the suspensions .

  24. 方法:对中国大耳白兔分别给予剂量为0.3g口服用麦迪霉素混悬剂、直肠用普通麦迪霉素栓剂及麦迪霉素微囊栓剂,管碟法测定麦迪霉素含量。

    Methods : The drug concentrations were determined by cylinder plat after a single oral dose of 0.3g preparation of suspension , suppository and micro capsule embolus in Chinese rabbits respectively .

  25. 自制AMO-CLA注射用混悬剂的主要动力学参数与辉瑞公司的AMO-CLA注射用混悬剂的动力学参数比较差异不显著。

    The main parameters of the pharmacokinetic had no significant difference between two preparations of AMO-CLA suspension made by Pfizer and ourselves .

  26. 目的:探讨肝癌经动脉注射碘油加抗癌药物混悬剂治疗术(LP-TAE)术后健脾理气药的应用价值。

    Objective : To study the effects of drug reinforcing spleen and regulating the flow of Qi applied in hepatocellular carcinoma ( HCC ) after LP TAE operation .

  27. 最优处方得到的槲皮素纳米结晶混悬剂在透射电镜下分散性好、圆整、均匀而不粘连,平均粒径为393.5nm,Zeta电位为-35.75mV,溶解度是原料药的70倍。

    The optimal quercetin loaded NS presented spherically shaped , uniform size and un-adhesion under transmission electron microscope . The mean particle size was 393.5 nm and the zeta potential was -35.75 mV . The solubility was significantly increased by NS about 70-fold compared to the crude drug .

  28. 结果不同制药公司及同一公司生产的不同批号的片剂、干混悬剂的溶出度基本上能达到《中华人民共和国药典》规定标准(即45min溶出度分别≥80%)。

    Results The dissolution of azithromycin tablets and azithromycin suspension from the different pharmaceutical companies basically meet the standard of Ch. P ( dissolution of 45 min have achieved ≥ 80 % ) .

  29. 伊维菌素干混悬剂对绵羊寄生虫的驱杀效果与安全性研究

    Effect and safety of ivermectin dry suspension agent against sheep parasites

  30. 磺胺嘧啶混悬剂处方的实验筛选及稳定性研究

    Studies on stability and orthogonal design of formula of Sulfadiazine Suspension